Results 211 to 220 of about 31,215 (290)

A Case of Oral Semaglutide for Treatment of Hepatocyte Nuclear Factor 4A Maturity-Onset Diabetes of the Young. [PDF]

AACE Endocrinol Diabetes
Grennan KN, Singh D, Chindris AM, Wilson JR.   +3 more
europepmc   +1 more source

Tests on Three Antisera und Subsequent Development of Radioimmunoassay for Different Regions of Human parathyrin [PDF]

, 1979
Marschner, I., Scriba, Peter Christian, Wood, W. G.   +2 more
core  

Patterns and Clinical Outcomes of Sitagliptin/Metformin Extended-Release in Internal Medicine: A Real-World Multicenter Italian Study. [PDF]

J Clin Med
De Luca M, Arcopinto M, Bosco G, Cicco S, Di Giacomo Barbagallo F, Giacinti C, Marozzi MS, Masala MS, Pinna M, Pucci G, Salzano A, Scicali R, Marra AM, Cittadini A, CLUB Study-Group.   +14 more
europepmc   +1 more source

The role of membrane excitability in pancreatic β-cell glucotoxicity [PDF]

, 2019
Nichols, Colin G., Remedi, Maria S., Shyr, Zeenat A., Wang, Zhiyu, York, Nathaniel W.   +4 more
core   +1 more source

Phenotypic heterogeneity and polygenic risk scores in a family of maturity-onset diabetes of the young. [PDF]

JCEM Case Rep
Chatchomchuan W, Thewjitcharoen Y, Nakasatien S, Himathongkam T, Lim CKP, Chan JCN.   +5 more
europepmc   +1 more source

Medication Deprescribing Practices Among Lifestyle Medicine Providers: A Cross-Sectional Survey. [PDF]

Am J Lifestyle Med
Macfield J, Staffier KL, Kelly J, Moghe R, Karlsen MC.   +4 more
europepmc   +1 more source

Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. [PDF]

Diabetes Care
Park CM, Thanapluetiwong S, Chen X, Oh G, Ko D, Kim DH.   +5 more
europepmc   +1 more source

QTc Interval and Its Associated Factors in Patient With Type 2 Diabetic Mellites. [PDF]

J Diabetes Res
Asmare DS, Abebe TA, Ashenef B, Baylie T, Shita Y.   +4 more
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 13 No. 1 [PDF]

, 1977

core   +1 more source

Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes.

JAMA Netw Open
Neugebauer R, An J, Dombrowski SK, Oshiro C, Cassidy-Bushrow A, Gilliam L, Simonson G, Karter AJ, Bergenstal R, Finertie H, Yassin MM, Knowlton G, Lin SR, Dyer W, Pimentel N, Izadian K, Schmittdiel J, Thomas TW, Hooker SA, Nolan MB, Wright E, Aurora L, Rodriguez LA, Kaur J, Adams AS, van der Laan MJ, O'Connor PJ.   +26 more
europepmc   +1 more source